Keytruda sales power Merck to quarterly beat

(Reuters) - Drugmaker Merck & Co reported a better-than-expected first-quarter profit on Tuesday, helped by a more than 150 percent rise in sales of cancer drug Keytruda.

Keytruda sales power Merck to quarterly beat
Read More


Bagikan Berita Ini